<?xml version="1.0" encoding="UTF-8"?>
<p>The patients comprised 13 men and 4 women, with a median age of 47 (24–86) years. Fourteen patients died at our institution and three were referred for autopsy. Sixteen patients lived or traveled to the epizootic areas of the city. One patient lived in urban area and had YF vaccine-associated viscerotropic disease (YEL-AVD), which was confirmed by liver RT-PCR. Six patients received YF vaccination 0–3 days before death; only one of them presented with YEL-AVD. One patient was a 24-year-old, 27-week pregnant woman. The median timespan between the occurrence of symptoms and hospital admission was 4 days (1–15) and that between the occurrence of symptoms and death was 8 days (6–21). The most frequent associated clinical conditions were 
 <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Alcoholism" xmlns:xlink="http://www.w3.org/1999/xlink">alcoholism</ext-link> (n = 7), smoking (n = 5), and systemic arterial hypertension (n = 4). One patient had undergone liver transplantation three days before death for hepatic failure due to YF. The primary symptoms upon hospital admission were fever, jaundice, myalgia, anorexia, abdominal pain and hemorrhagic phenomena. The main alterations in the laboratory data were related to acute liver failure, as well as renal dysfunction and metabolic acidosis.
</p>
